Can a safer nerve block match the gold standard for Post-Mastectomy pain?

NCT ID NCT07738770

First seen Jul 31, 2026 ยท Last updated Jul 31, 2026

Summary

This trial tests whether a combination of two ultrasound-guided nerve blocks (PECS II and superficial PIP) can provide pain relief and recovery quality comparable to the standard thoracic paravertebral block after mastectomy. The standard block is effective but carries a risk of lung puncture. The study will enroll women aged 18-60 undergoing mastectomy, randomly assigning them to receive either the combined block or the standard block. Pain scores, opioid use, time to first pain medication request, and recovery quality will be tracked for 24 hours after surgery.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Combined PECS II and superficial PIP nerve block versus thoracic paravertebral block, using bupivacaine
What this could lead to
If the combined nerve block works as well as or better than the standard one, it could offer a safer option for managing pain after mastectomy, potentially reducing complications and improving recovery.
What could go wrong
This is a small, early-stage trial, so results may not apply to all patients. The combined block might not provide adequate pain relief, and there is a risk of block-related complications or side effects from the local anesthetic.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Acute Pain breast cancer breast neoplasm Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dharmais National Cancer Center Hospital

    RECRUITING

    Jakarta, DKI Jakarta, 11420, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.